Ethics Education to Support Nurse Leaders in HealthCare

April 28, 2025 updated by: Jill K. Greenwood-Williamson, OSF Healthcare System

Ethics Education Supporting Acute and Post-Acute Nurse Leaders - 2nd Cohort

Using an exploratory study design with an educational intervention, a pre/post evaluation of ethical confidence and competence will be completed for nursing leaders working in either acute care or post-acute care with primary purpose to increase ethical competency and confidence in decision making for nursing leaders in a clinical role.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

The purpose of this project is to implement an ethics educational program that has been developed in collaboration with subject matter experts to support patient facing nursing leaders. The intervention is an ethics education pathway, which will be used for approximately 60-80 patient-facing nurse leaders who practice in either acute care or post-acute care over a 6-week period. One Pre and two post-assessment questionnaires will be distributed, which include the "Ethical Competence Support Questionnaire" © and the "Ethical Safety Questionnaire" ©. Permission for the instrument use was obtained from the author.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Illinois
      • Peoria, Illinois, United States, 61602
        • OSF Healthcare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • employment within an in-patient or outpatient non-profit healthcare setting as a nursing leader.
  • settings include acute-care units and post-acute care facilities

Exclusion Criteria:

  • nurses working direct care 100% of their time without any formal leadership responsibilities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acute Care
Nursing leaders will participate voluntarily and will report their leadership role as acute care (hospital settings).
Behavioral: Educational intervention
Professional development program provided online to small groups of professional nurse leaders via an educational platform over a 6-week period.
Experimental: Post-Acute Care
Nursing leaders will participate voluntarily and will report their leadership role as post-acute care (ambulatory settings)
Behavioral: Educational intervention
Professional development program provided online to small groups of professional nurse leaders via an educational platform over a 6-week period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ethical Competence Support Questionnaire
Time Frame: change from baseline in the ethical competence measure at 6 weeks after initiation.
The ethical competence support questionnaire contains 27 items addressing four subcategories: encouragement of ethical activity, provision of information on ethical issues, dealing with ethical issues, and conversational support. A 5-point Likert Scale is used for measurement: Strong disagree to Strongly Agree. Minimum value = 1 maximum value =5.
change from baseline in the ethical competence measure at 6 weeks after initiation.
Ethical Safety Questionnaire
Time Frame: change from baseline in the ethical safety measure at 6 weeks after initiation.
The ethical safety questionnaire contains11 items addressing four subcategories: general ethical safety, ethical autonomy, ethical respect, and ethical competence. A 5-point Likert Scale is used for measurement: Strong disagree to Strongly Agree. Minimum value = 1 maximum value =5.
change from baseline in the ethical safety measure at 6 weeks after initiation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ethical Confidence Assessment
Time Frame: change from baseline in the ethical competence measure at 6 weeks following initiation and at 3 months.
Confidence as a nurse leader for ethical decision making is rated on a 1-10 scale. 0=not confident 10= very confident
change from baseline in the ethical competence measure at 6 weeks following initiation and at 3 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

OSF Healthcare System

Investigators

  • Principal Investigator: Jill K Greenwood-Williamson, DNP, RN, OSF Healthcare

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 2, 2024

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

June 17, 2024

First Submitted That Met QC Criteria

June 17, 2024

First Posted (Actual)

June 24, 2024

Study Record Updates

Last Update Posted (Actual)

May 1, 2025

Last Update Submitted That Met QC Criteria

April 28, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2193504

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knowledge, Attitudes, Practice

Clinical Trials on Educational intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe